High-cost multivitamin prior authorization policy
Customize your policy alerts
Sign up for all Neighborhood Health Plan of Rhode Island policy alerts
Know when Neighborhood Health Plan of Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines prior authorization requirements for multivitamin prescriptions above a $50 per-fill maximum cost edit for Neighborhood Health Plan of Rhode Island Medicaid FIDE SNP members. Affects pharmacy claims adjudication and prescribing providers.
A maximum cost edit was implemented for multivitamin preparations such that fills under $50 adjudicate without authorization while fills above $50 require prior authorization.
Coverage Criteria
Initial Authorization
Covered when ALL of the following are met
Initial authorization criteria
- A. The requested drug/product is being used per the product's labeling or for an FDA-approved indication or a medically accepted indication as defined in AHFS-DI, Thomson Micromedex DrugDex, Clinical Pharmacology, Wolters Kluwer Lexi-Drugs, or peer-reviewed published medical literature.
- B. The prescribed dose and quantity fall within the product's labeling or within FDA- or compendia-supported dosing guidelines.
- C. The member has tried and failed at least 3 formulary alternative multivitamin preparations; documentation of the tried and failed alternatives must be submitted.
- D. The prescriber has submitted clinical evidence (e.g., published comparative study results) showing that the requested high-cost multivitamin preparation is clinically superior to at least one of the tried and failed formulary alternatives.
Authorization up to 12 months if approved.
Continuation of Therapy
Covered when ALL of the following are met
Continuation approvals rely on persistence of initial approval criteria.
Fills with a cost per fill of $50 or less are excluded from prior authorization and will adjudicate at point-of-sale without requiring prior approval. Any multivitamin fill with a reported cost per fill greater than $50 will reject at point-of-sale due to the maximum cost edit and will require submission of a prior authorization request.
Initial Therapy
Initial Therapy
Initial authorization requirement for high-cost multivitamin fills (> $50 per fill)
Prior authorization is required for fills with cost per fill above the $50 maximum cost edit; approvals may be granted up to 12 months when criteria met.
Continuation Therapy
Continuation Therapy
Continuation authorization requirement
Continuation approvals valid up to the coverage duration.
Provider Actions & Requirements
Prior Authorization Required
Prior authorization is required for multivitamin prescriptions with a cost per fill above $50. Claims with a per‑fill cost greater than $50 will reject at point‑of‑sale under Neighborhood's maximum cost edit and will not adjudicate without an approved prior authorization.
- Cost threshold: $50 per fill
- Point‑of‑sale rejection triggers prior authorization requirement
Required Failures of Formulary Alternatives
Members must have tried and failed at least three formulary alternative multivitamin preparations before a high‑cost multivitamin authorization will be approved. The prescriber must document each trial and the reason for failure (for example: lack of efficacy, adverse reaction, intolerance, allergy, or nonresponse).
- Minimum required failures: 3 formulary alternatives
- Document reason for each failure (efficacy, adverse reaction, intolerance, allergy, nonresponse)
Required Documentation for Authorization
Submit the following documentation with the prior authorization request: indication for use, dose and quantity requested, date(s) and details of trials of each formulary alternative (including dose and duration), clinical rationale for why alternatives were inadequate, and supporting clinical records or literature. If claiming superiority of the requested product, include relevant published comparative studies or peer‑reviewed evidence.
- Indication and dosing (must align with labeling or referenced compendia)
- Details of 3+ formulary alternative trials: drug name, dose, dates, duration, and reason for failure
- Clinical evidence demonstrating superiority (published studies or compendia references)
- Relevant supporting clinical records (office notes, lab results)
Cost Edit Rejection
Neighborhood's pharmacy system enforces a maximum cost edit for multivitamins: fills with a per‑fill cost over $50 will reject at the pharmacy benefit point‑of‑sale. These claims will require submission and approval of a prior authorization before the claim will adjudicate.
- Maximum cost edit: $50 per fill
- Claims > $50 will reject at point‑of‑sale and require prior authorization
Coding & Cost Edit
Step Therapy Requirements
| Step requirement | Required documentation |
|---|---|
| Trial and failure of at least three formulary alternative multivitamin preparations | |
| Documentation of each tried and failed alternative (e.g., medication names, dates of trial, reason for failure) must be submitted | |
| Use per product labeling or FDA/medically accepted indication as defined by listed compendia | |
| Evidence that the requested product is used per labeling or a medically accepted indication (reference to AHFS‑DI, DrugDex, Clinical Pharmacology, Lexi‑Drugs, or peer‑reviewed literature) | |
| Prescribed dose and quantity within labeling or compendia‑supported dosing | |
| Prescription details confirming dose and quantity fall within product labeling or FDA/compendia dosing guidelines | |
| Clinical evidence of superiority over at least one tried alternative | |
| Attach clinical evidence (e.g., published comparative study results) demonstrating the requested high‑cost multivitamin is clinically superior to at least one tried and failed formulary alternative |
Definitions
Background
Neighborhood implemented a maximum cost edit on multivitamin preparations to reduce fraud, waste, and abuse (FWA) while preserving access to clinically necessary, higher-cost formulations. The cost threshold was set after utilization review of 2024–2025 claims data: the average multivitamin fill cost (excluding extreme outliers > $1,000) was approximately $1.39, and the threshold was chosen to be at least five times that average so that routine low-cost fills adjudicate without authorization but higher-cost fills undergo clinical review. Under this policy, fills above the $50 per fill limit will reject and require prior authorization to ensure appropriate medical necessity and documented justification.
Revision History
Policy effective date; a maximum cost edit of $50 per fill for multivitamin preparations implemented such that fills at or below $50 adjudicate without prior authorization while fills above $50 require prior authorization (material change).
Maximum cost edit operationalized for 2026 based on 2024–2025 utilization analysis to prevent fraud, waste, and abuse while allowing access to certain injectable formulations.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.